TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedPhase 1

Our Family Our Future: Acceptability and Feasibility Study of a Family Prevention Program for HIV Risk and Depression

The purpose of this study is to assess the feasibility and acceptability of a family-based preventive intervention designed to reduce sexual risk behaviors and depressive symptoms among South African adolescents and their parents/guardians/

Cape Town, Western Cape, South AfricaView details
Not yet recruitingN/A

Enhancing Slow Wave Sleep in Depression

The goal of this pilot study is to determine if non-invasive brain stimulation during sleep can increase deep sleep in adults with depression. It will also determine if increased deep sleep improves cognitive performance and mood ratings.

Winston-Salem, North Carolina, United StatesView details
Completed

Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in Depression

According to the World Health Organization, MDD is attributed as the leading cause of disability worldwide, leaving 300 million individuals affected. Despite the efficacy of pharmacotherapy, a subset of MDD patients, classified as TRD, exhi

Toronto, Ontario, CanadaView details
CompletedPhase 2

Cognitive Training to Improve Work Outcomes in Severe Mental Illness

This study will compare the efficacy of two types of supportive treatments for a program called Individual Placement and Support, which helps people with severe mental illnesses find and keep jobs.

San Diego, California, United StatesView details
CompletedPhase 3

Study of Antidepressants in Parkinson's Disease

The purpose of this study is to find out if two antidepressant medications, paroxetine and venlafaxine, can help control depression in Parkinson's disease, and if these medications affect the motor symptoms of Parkinson's disease such as tr

San Francisco, California, United States+17 moreView details
Not yet recruitingN/A

Marine Lipids Ease Painful TMD

The ADAPT study is a single-site, Phase 2b, randomized, quadruple-masked, placebo-controlled trial evaluating an omega-3 dietary supplement enriched with specialized pro-resolving mediator (SPM) precursors in adults with chronic temporomand

Chapel Hill, North Carolina, United StatesView details
TerminatedPhase 3

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

The specific aim of this study is to evaluate the efficacy and tolerability of lisdexamfetamine in the adjunctive treatment of bipolar disorder.

Mason, Ohio, United StatesView details
CompletedN/A

Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy

This study aims to evaluate the efficacy of 4 weeks of daily light exposure in reducing Post-Traumatic Brain Injury (TBI) Fatigue immediately post-treatment and at a one-month follow up. The investigators hypothesize that individuals receiv

New York, New York, United StatesView details
Unknown

Fatigue, Depression, and Cortical Excitability in Systemic Lupus

Systemic lupus erythematosus is a chronic inflammatory autoimmune disease with an unknown cause and many challenges. Whilst corticosteroids and effective immunosuppressive therapy have transformed the management of patients with active syst

Multiple locationsView details
UnknownN/A

The Effect of Increasing Physical Activity or Reducing Mobile Phone Use on Mental Health in Young People in Austria

Introduction: Data show adolescent mental health has declined in recent years, possibly due to increased uncertainty and loss of opportunities. The SPARKY study aims to test an at-home intervention which aims to promote autonomous healthy l

Krems, Lower Austria, AustriaView details
By invitationN/A

Behavioral Telehealth in Low-resource Primary Care Settings for Anxiety and Depression in Youth

The goal of this clinical trial is to test a brief, behavioral telehealth treatment program (STEP-UP) for depression and anxiety in youths (age 8-16 years old). Youths and families will be recruited through participating community health ce

Portland, Oregon, United StatesView details
Completed

Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19)

Introduction: Coronavirus disease 2019 (COVID-19) is a new pathology, declared a public health emergency by the World Health Organization, which can have negative consequences for pregnant women and their newborns. It is estimated that 1 in

Tirana, Albania+12 moreView details
RecruitingN/A

Co-occurence of Mental Illness and Problematic Alcohol Use: an Internet-based Cognitive Behavior Therapy Intervention

The goal of this clinical trial is to learn if internet-based cognitive behavior therapy (ICBT ) works to treat co-occurent of problematic alcohol use and mental illness including mild to moderate symptoms of either depression, anxiety, str

Linköping, Sweden+1 moreView details
CompletedPhase 2

Beyond Ageing Project: A Study for the Prevention of Depression

The purpose of this study is to determine whether folate and vitamin B12, physical activity and mental health literacy can prevent depression, and folate and vitamin B12 and physical activity can prevent cognitive impairment in older people

Canberra, Australian Capital Territory, AustraliaView details
Recruiting

Study on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With Depression

The incidence of type 2 diabetes with comorbid depression (T2DD) is notably high, characterized by prolonged disease duration and susceptibility to recurrence. The preliminary experiments identified 5-AVAB, a gut microbiota-derived metaboli

Nantong, Jiangsu, ChinaView details
Not yet recruitingN/A

Ketogenic Diet and Neuromodulation in Treatment Resistant Depression

The goal of this clinical trial is to test whether combining a ketogenic diet (KD) with personalized, accelerated intermittent theta burst stimulation (iTBS) produces greater reductions in depressive symptoms than iTBS combined with a stand

Toronto, Ontario, CanadaView details
TerminatedPhase 2

Rapid Antidepressant Effects of Leucine

This randomized double-blind placebo-controlled crossover study seeks to evaluate the antidepressant effect of L-leucine, an essential amino acid, in patients with Major Depressive Disorder (MDD).

Dallas, Texas, United StatesView details
CompletedEARLY_Phase 1

PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A

Background: \- A small brain protein called nociceptin/orphanin FQ peptide (NOP) receptor may be involved in several brain diseases such as anxiety, depression, drug abuse, and seizures. Researchers are interested in testing a new radioact

Bethesda, Maryland, United StatesView details
CompletedN/A

Efficacy of Telepsychiatry in the Treatment of Depression

Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care. If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment, then many individu

Baltimore, Maryland, United StatesView details
Completed

Using Affective Differences to Predict Response to Behavioral Treatment for Major Depressive Disorder

This study will determine how people with depression differ from healthy people in brain activity and interpreting emotions, both before and after receiving a psychotherapy treatment.

Multiple locationsView details
Load more trials